• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

Comprehensive Overview of 2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid (CAS No. 1824096-23-2)

2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid (CAS No. 1824096-23-2) is a highly specialized chemical compound gaining attention in pharmaceutical and agrochemical research. This fluorinated isonicotinic acid derivative exhibits unique properties due to its trifluoromethyl and dichloro functional groups, making it a valuable intermediate in synthetic chemistry. Researchers are increasingly exploring its potential in crop protection and drug discovery, aligning with current trends in sustainable agriculture and precision medicine.

The molecular structure of 2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid features a pyridine ring substituted with electron-withdrawing groups, which enhances its reactivity in cross-coupling reactions. This characteristic has sparked interest in its application for developing novel heterocyclic compounds, particularly in the context of catalyzed amidation processes. Recent patent literature highlights its utility in creating bioactive molecules with improved metabolic stability, addressing the pharmaceutical industry's demand for compounds with enhanced ADME properties.

From an environmental perspective, the trifluoromethyl group in CAS 1824096-23-2 contributes to the compound's lipophilicity, a property critically evaluated in modern green chemistry initiatives. Analytical studies using HPLC-MS have demonstrated its stability under various pH conditions, making it suitable for formulation development. These findings respond to growing market inquiries about stable fluorinated intermediates for industrial applications.

In material science, the crystalline form of 2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid has shown interesting solid-state properties, with X-ray diffraction studies revealing potential for cocrystal engineering. This aligns with current research trends in pharmaceutical crystallography and answers frequent search queries regarding fluorine-containing crystal design. The compound's thermal behavior, characterized by differential scanning calorimetry, further supports its utility in high-performance material synthesis.

Quality control protocols for CAS 1824096-23-2 typically involve NMR spectroscopy (1H, 13C, and 1?F) and elemental analysis, addressing common questions about fluorinated compound characterization. The synthetic route optimization has been a focus area, with recent publications describing improved yields through microwave-assisted synthesis techniques. These advancements cater to the chemical industry's need for cost-effective production methods of specialized intermediates.

Regulatory aspects of 2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid comply with major REACH guidelines, with safety data sheets emphasizing proper laboratory handling procedures. This information responds to frequent searches about chemical safety protocols for fluorinated compounds. Storage recommendations typically suggest anhydrous conditions to maintain stability, a detail often queried by procurement specialists.

The commercial availability of 1824096-23-2 through specialty chemical suppliers has increased in recent years, reflecting growing demand for halogenated nicotinic acid derivatives. Market analysis indicates particular interest from contract research organizations and generic pharmaceutical developers. Pricing trends show correlation with fluorine raw material markets, a connection often explored in industry reports.

Future research directions for 2,3-Dichloro-6-(trifluoromethyl)isonicotinic acid may explore its potential in metal-organic frameworks (MOFs) or as a ligand in catalytic systems. These applications would leverage its structural features while addressing current scientific interests in advanced functional materials. The compound's versatility ensures its continued relevance across multiple high-tech chemical sectors.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)